The effect of TNF-alpha, Fc?R and CD1 polymorphisms on Guillain-Barré syndrome risk: evidences from a meta-analysis
Autor(es): Wu Li-Ya,Zhou You,Qin Chao,Hu Bang-Li
Resumo: The findings on the associations between potential genetic variants and risk of Guillain-Barré syndrome (GBS) are controversial. We conducted a meta-analysis for candidate genes to provide the evidences for the current understanding of the genetic association with GBS. We searched relevant studies without language restriction in PubMed, Embase and Cochrane library through May 2011. The strengths of the associations between genetic variants and GBS risk were estimated by odds ratios (ORs) with 95% confidence intervals (CIs). Random-effects models or fixed effects model was applied based on the heterogeneity test. We identified 12 case-control studies involving 1,590 GBS cases and 2,154 controls for the analysis. Because of limited eligible data, our meta-analysis specifically focused on 6 genetic variants of 3 candidate genes, TNF-?, Fc?R and CD1. We found that TNF-? 308 G/A polymorphism was significantly associated with the risk of GBS in the overall population (GG+GA vs. AA: OR=0.32, 95%CI=0.16-0.62; GG vs. AA: OR=0.36, 95%CI=0.19-0.68). Subgroup analysis further provided evidence of significant association between TNF-? 308 G/A and risk of the GBS in Asian population (GG+GA vs. AA: OR=32, 95%CI=0.11-0.93; GG vs. AA: OR=0.32, 95%CI=0.15-0.68). In addition, we did not observe significant associations between Fc?RIIA R/H, Fc?RIIIA F/V, Fc?RIIIB NA1/NA2, CD1A 1/2 and CD1E 1/2 polymorphisms and susceptibility for developing GBS. Our findings showed that TNF-? 308A allele might be a moderate risk factor for GBS. However, the results should be interpreted with caution due to the limited number of studies available.
Palavras-Chave: Guillain-Barré syndrome; Gene polymorphism; Meta-analysis
Imprenta: Journal of Neuroimmunology, v. 243, n. 1-2, p. 18-24, 2012
Identificador do objeto digital: 10.1016/j.jneuroim.2011.12.003
Descritores: Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Cytokines ; Guillain-Barre Syndrome - Public health
Data de publicação: 2012
